Likes
Work life balance and good salary. But that's not the key for longevity.
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
Nestle Regulatory Affairs Manager Salary
8 - 11 years exp. (3 salaries) | ₹17 L/yr - ₹21 L/yr
20%
less | |
Sun Pharmaceutical Industries Regulatory Affairs Manager Salary
8 - 15 years exp. (17 salaries) | ₹6.5 L/yr - ₹14.6 L/yr
48%
less | |
Login to view exact salary
| ||
Lupin Regulatory Affairs Manager Salary
8 - 21 years exp. (15 salaries) | ₹8.7 L/yr - ₹20.1 L/yr
35%
less | |
Abbott Regulatory Affairs Manager Salary
8 - 15 years exp. (15 salaries) | ₹12.6 L/yr - ₹23 L/yr
20%
less | 1 job opening |
Glenmark Pharmaceuticals Regulatory Affairs Manager Salary
9 - 17 years exp. (13 salaries) | ₹15 L/yr - ₹24.5 L/yr
16%
less | 1 job opening |
AstraZeneca Regulatory Affairs Manager Salary
7 - 10 years exp. (11 salaries) | ₹19.5 L/yr - ₹26 L/yr
2%
less | |
Dr. Reddy's Regulatory Affairs Manager Salary
10 - 12 years exp. (7 salaries) | ₹9 L/yr - ₹22 L/yr
28%
less | |
Pfizer Regulatory Affairs Manager Salary
10 - 14 years exp. (5 salaries) | ₹16.4 L/yr - ₹19.7 L/yr
26%
less | |
Alkem Laboratories Regulatory Affairs Manager Salary
12 - 17 years exp. (5 salaries) | ₹13.9 L/yr - ₹23 L/yr
24%
less | |
Torrent Pharmaceuticals Regulatory Affairs Manager Salary
11 - 15 years exp. (4 salaries) | ₹16 L/yr - ₹27.4 L/yr
12%
less | |
Cipla Regulatory Affairs Manager Salary
10 - 13 years exp. (4 salaries) | ₹10 L/yr - ₹15 L/yr
51%
less | |
Login to view exact salary
| ||
Akums Drugs & Pharmaceuticals Limited Regulatory Affairs Manager Salary
9 - 11 years exp. (3 salaries) | ₹12 L/yr - ₹13.5 L/yr
43%
less | |
Last Updated: 21 Dec 2023
Experience | Avg Annual Salary |
---|---|
9 years (AmbitionBox Estimate) |
₹20.7
L/yr
- ₹26.5
L/yr
|
10 years (AmbitionBox Estimate) |
₹20.7
L/yr
- ₹26.5
L/yr
|
Login to view exact salary
| |
11 years (AmbitionBox Estimate) |
₹20.7
L/yr
- ₹26.5
L/yr
|
12 years (AmbitionBox Estimate) |
₹20.7
L/yr
- ₹26.5
L/yr
|
Discover interview dos and don'ts from real experiences
Top trending discussions